AMD stock jumps 6% as earnings countdown starts and valuation debate flares
21 January 2026

AMD stock jumps 6% as earnings countdown starts and valuation debate flares

New York, Jan 21, 2026, 10:44 EST

  • AMD shares climbed roughly 6.6% in morning deals, extending gains from Tuesday’s finish
  • On Feb. 3, the chipmaker will report results, with investors closely watching its outlook on AI and data-center chips
  • Recent market commentaries are divided: some call it a “rebound,” while others warn valuations remain stretched

Shares of Advanced Micro Devices climbed roughly 6.6% to $247.28 in early trading Wednesday, pushing the chipmaker’s recovery further after a volatile week for U.S. equities.

AMD is set to release its fiscal fourth-quarter and full-year 2025 results on Feb. 3 after the market closes. The company will hold a conference call at 5 p.m. EST, it announced earlier this month.

The results matter because AMD is positioned between two major spending waves — cloud data centers and AI. Investors are watching closely to see if demand for its server CPUs and “AI accelerators” (specialised chips for training and running AI models) remains strong, and what profit margins it’s delivering.

A MarketBeat commentary on Investing.com Tuesday suggested AMD’s selloff from late 2025 might have bottomed out, highlighting the upcoming MI450 data-center GPUs as a likely trigger for a rebound in 2026.

TechStock², another market watcher, warned that tariff news and inflation figures might shake up “high-beta” tech stocks—those that tend to move more sharply than the overall market. Stephen Innes of SPI Asset Management described it as a “slow rebalancing story,” while the article highlighted a shift from AI “training” spending to “inferencing,” meaning running AI models live. TechStock²

A note from Simply Wall St on Monday took a more cautious view on valuation. AMD was trading near $231.83 then, below the average analyst price target of roughly $283.75. But the stock’s P/E ratio stood at about 120.5 times, far above the 43.4 times seen in the U.S. semiconductor sector.

Competitive pressure remains intense. Nvidia continues to lead the high-end AI chip market, while Intel is preparing to release its earnings on Thursday. Traders often watch Intel’s report closely for clues about server demand across the industry.

On Tuesday, AMD revealed a new addition to its board: KC McClure, who previously served as CFO at Accenture. CEO Lisa Su described her as “a proven finance leader” in the announcement. Advanced Micro Devices, Inc.

That rally trims the margin for error. Should key cloud clients push back on orders, or if AMD’s rollout of new AI gear drives up costs before sales catch up, expect the stock to lose ground quickly.

Macro risk remains on the radar. The Commerce Department will release the PCE price index, a key inflation measure, on Jan. 22. This report could shake up rate-sensitive growth stocks, even if there’s no fresh company news.

AMD announced that its chief technology officer, Mark Papermaster, is set to speak at Morgan Stanley’s Technology, Media & Telecom Conference on March 3 — a date investors often watch closely for potential roadmap updates.

Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

AerCap

NYSE: AER 95 / 100
#2 BUY

Constellation Energy

NASDAQ: CEG 94 / 100
#3 BUY ON PULLBACK

Cheniere Energy

NYSE: LNG 92 / 100
#4 BUY

Walt Disney

NYSE: DIS 90 / 100
#5 ACCUMULATE

AIG

NYSE: AIG 88 / 100
View full portfolio
Editorial model selection. Not personalised advice.
Strategy Inc (MSTR) stock rebounds after $2.1B bitcoin buy — dilution risk and Feb. 5 earnings ahead
Previous Story

Strategy Inc (MSTR) stock rebounds after $2.1B bitcoin buy — dilution risk and Feb. 5 earnings ahead

Boston Scientific stock steadies after FDA flags AXIOS stent issue; Penumbra deal still in play
Next Story

Boston Scientific stock steadies after FDA flags AXIOS stent issue; Penumbra deal still in play